Orthostatic hypotension during combination chemotherapy with vincristine (NSC 67574)

J. Aisner; H. D. Weiss; P. Chang; P. H. Wiernik

Orthostatic hypotension during combination chemotherapy with vincristine (NSC 67574)

J. Aisner, H. D. Weiss, P. Chang, P. H. Wiernik

Research output: Contribution to journal › Article › peer-review

Abstract

Severe orthostatic hypotension developed in 4 patients with cancer during combination chemotherapy which included vincristine. It is believed the orthostatic hypotension may be a manifestation of vincristine neurotoxicity. Milder degrees of orthostatic hypotension may be a relatively common complication of this chemotherapeutic agent.

Original language	English (US)
Pages (from-to)	927-930
Number of pages	4
Journal	CANCER CHEMOTHER.REP.
Volume	58
Issue number	6
State	Published - 1974
Externally published	Yes

All Science Journal Classification (ASJC) codes

Medicine(all)

Cite this

@article{ea653867356141b6ac50a45e21cb4eb2,

title = "Orthostatic hypotension during combination chemotherapy with vincristine (NSC 67574)",

abstract = "Severe orthostatic hypotension developed in 4 patients with cancer during combination chemotherapy which included vincristine. It is believed the orthostatic hypotension may be a manifestation of vincristine neurotoxicity. Milder degrees of orthostatic hypotension may be a relatively common complication of this chemotherapeutic agent.",

author = "J. Aisner and Weiss, {H. D.} and P. Chang and Wiernik, {P. H.}",

year = "1974",

language = "English (US)",

volume = "58",

pages = "927--930",

journal = "CANCER CHEMOTHER.REP.",

publisher = "Cancer Chemotherapy National Service Center",

number = "6",

}

TY - JOUR

T1 - Orthostatic hypotension during combination chemotherapy with vincristine (NSC 67574)

AU - Aisner, J.

AU - Weiss, H. D.

AU - Chang, P.

AU - Wiernik, P. H.

PY - 1974

Y1 - 1974

N2 - Severe orthostatic hypotension developed in 4 patients with cancer during combination chemotherapy which included vincristine. It is believed the orthostatic hypotension may be a manifestation of vincristine neurotoxicity. Milder degrees of orthostatic hypotension may be a relatively common complication of this chemotherapeutic agent.

AB - Severe orthostatic hypotension developed in 4 patients with cancer during combination chemotherapy which included vincristine. It is believed the orthostatic hypotension may be a manifestation of vincristine neurotoxicity. Milder degrees of orthostatic hypotension may be a relatively common complication of this chemotherapeutic agent.

UR - http://www.scopus.com/inward/record.url?scp=0016332655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016332655&partnerID=8YFLogxK

M3 - Article

C2 - 4447927

AN - SCOPUS:0016332655

VL - 58

SP - 927

EP - 930

JO - CANCER CHEMOTHER.REP.

JF - CANCER CHEMOTHER.REP.

IS - 6

ER -

Orthostatic hypotension during combination chemotherapy with vincristine (NSC 67574)

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this